What Does Unexpected Suboptimal Response During Ovarian Stimulation Suggest, an Overlooked Group?
Wang B, Liu W, Liu Y, Zhang W, Ren C, Guan Y.
Front Endocrinol (Lausanne). 2021 Dec 22;12:795254. doi: 10.3389/fendo.2021.795254. eCollection 2021.
Ovarian response to stimulation and suboptimal endometrial development are associated with adverse perinatal outcomes in intracytoplasmic sperm injection cycles.
Borges E Jr, Zanetti BF, Braga DPAF, Setti AS, Figueira RCS, Iaconelli A Jr.
JBRA Assist Reprod. 2019 Apr 30;23(2):123-129. doi: 10.5935/1518-0557.20190001.
Clinical Features and Management of Suboptimal Ovarian Response During in vitro Fertilization and Embryo Transfer: Analysis Based on a Retrospective Cohort Study.
Yan Y, Qu R, Ma X, Qin S, Chen L, Ni X, Yang R, Wang Y, Li R, Qiao J.
Front Endocrinol (Lausanne). 2022 Jul 22;13:938926. doi: 10.3389/fendo.2022.938926. eCollection 2022.
Ovarian response to controlled ovarian hyperstimulation: what does serum FSH say?
Oudshoorn SC, van Tilborg TC, Hamdine O, Torrance HL, Eijkemans MJC, Lentjes EGWM, Lambalk CB, Broekmans FJM.
Hum Reprod. 2017 Aug 1;32(8):1701-1709. doi: 10.1093/humrep/dex222.
Association of 'normal' early follicular FSH concentrations with unexpected poor or suboptimal response when ovarian reserve markers are reassuring: a retrospective cohort study.
Del Gallego R, Lawrenz B, Ata B, Kalafat E, Melado L, Elkhatib I, Fatemi H.
Reprod Biomed Online. 2024 Mar;48(3):103701. doi: 10.1016/j.rbmo.2023.103701. Epub 2023 Nov 10.
Elective Single Cleavage-Stage Embryo Transfer in IVF Patients with Suboptimal Ovarian Response is Not Detrimental to Cumulative Pregnancy and Reduces Multiple Pregnancy Rates.
Paffoni A, Cesana S, Corti L, Wyssling H, Kunderfranco A, Bianchi MC.
J Obstet Gynaecol India. 2023 Aug;73(4):329-335. doi: 10.1007/s13224-023-01768-6. Epub 2023 Jun 7.
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical Trial.
Li N, Zhu J, Yin R, Wang J, Pan L, Kong B, Zheng H, Liu J, Wu X, Wang L, Huang Y, Wang K, Zou D, Zhao H, Wang C, Lu W, Lin A, Lou G, Li G, Qu P, Yang H, Zhang Y, Cai H, Pan Y, Hao M, Liu Z, Cui H, Yang Y, Yao S, Zhen X, Hang W, Hou J, Wang J, Wu L.
JAMA Oncol. 2023 Sep 1;9(9):1230-1237. doi: 10.1001/jamaoncol.2023.2283.
Development and validation of a prediction model for suboptimal ovarian response in polycystic ovary syndrome (PCOS) patients undergoing GnRH-antagonist protocol in IVF/ICSI cycles.
Xu X, Jiang Y, Du J, Sun H, Wang X, Zhang C.
J Ovarian Res. 2024 May 28;17(1):116. doi: 10.1186/s13048-024-01437-w.
Clinical factors associated with unexpected poor or suboptimal response in Poseidon criteria patients.
Hochberg A, Dahan MH, Yarali H, Vuong LN, Esteves SC.
Reprod Biomed Online. 2024 Jul;49(1):103852. doi: 10.1016/j.rbmo.2024.103852. Epub 2024 Jan 30.
Prediction of ovarian response using the automated Elecsys anti-Mullerian hormone assay in gonadotrophin-releasing hormone antagonist cycles.
Bosch E, Labarta E, Zuzuarregui J, Iliodromiti S, Nelson SM.
Reprod Biomed Online. 2023 Feb;46(2):295-301. doi: 10.1016/j.rbmo.2022.10.012. Epub 2022 Nov 1.
